In addition to their anti-inflammatory effect, which seems beneficial in atherosclerosis, anti-TNFα agents could correct endothelial dysfunction and lipid profile abnormalities reported in chronic inflammatory diseases [11,46]. The gene discussed is TNF; the disease is endothelial dysfunction.